• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PRRX1 通过 p53 依赖性信号通路下调预示肝细胞癌预后不良。

Downregulation of PRRX1 via the p53-dependent signaling pathway predicts poor prognosis in hepatocellular carcinoma.

机构信息

Department of Laparoscopy, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, P.R. China.

The First Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, P.R. China.

出版信息

Oncol Rep. 2017 Aug;38(2):1083-1090. doi: 10.3892/or.2017.5785. Epub 2017 Jul 3.

DOI:10.3892/or.2017.5785
PMID:28677793
Abstract

Paired-related homeobox 1 (PRRX1) has been identified as a novel molecule associated with induction of epithelial-mesenchymal transition (EMT), acquisition of cancer stem cell like properties and poor prognosis in tumors. However, the function of PRRX1 in hepatocellular carcinoma has not been elucidated. In the present study, we observed that PRRX1 expression levels were downregulated and positively correlated with the downregulated expression of p53 in hepatocellular carcinoma specimens. Decreased expression of PRRX1 and/or p53 by siRNA induced both the migration and the invasion features of HCC cells in vitro. Furthermore, the loss of PRRX1 inhibits hepatocellular carcinoma (HCC) cell apoptosis, an anti-apoptotic expression profile was upregulated accompanied by downregulated expression of p53. HCC patients with low-expression of both PRRX1 and p53 had a significantly shorter overall and disease-free survival. These findings demonstrate that PRRX1 plays an important role in metastasis and apoptosis of HCC cells through the p53-dependent signaling pathway and is expected to become a novel biomarker associated with patient prognosis and survival.

摘要

配对相关同源盒 1(PRRX1)已被鉴定为一种与上皮-间充质转化(EMT)的诱导、获得癌症干细胞样特性以及肿瘤预后不良相关的新型分子。然而,PRRX1 在肝细胞癌中的功能尚未阐明。在本研究中,我们观察到 PRRX1 的表达水平下调,并且与肝细胞癌标本中 p53 的下调表达呈正相关。siRNA 下调 PRRX1 和/或 p53 的表达均可诱导 HCC 细胞在体外的迁移和侵袭特征。此外,PRRX1 的缺失抑制了肝细胞癌(HCC)细胞的凋亡,同时伴随着 p53 的下调而上调抗凋亡表达谱。PRRX1 和 p53 均低表达的 HCC 患者的总生存期和无病生存期明显缩短。这些发现表明,PRRX1 通过 p53 依赖性信号通路在 HCC 细胞的转移和凋亡中发挥重要作用,有望成为与患者预后和生存相关的新型生物标志物。

相似文献

1
Downregulation of PRRX1 via the p53-dependent signaling pathway predicts poor prognosis in hepatocellular carcinoma.PRRX1 通过 p53 依赖性信号通路下调预示肝细胞癌预后不良。
Oncol Rep. 2017 Aug;38(2):1083-1090. doi: 10.3892/or.2017.5785. Epub 2017 Jul 3.
2
Downregulation of PRRX1 Confers Cancer Stem Cell-Like Properties and Predicts Poor Prognosis in Hepatocellular Carcinoma.PRRX1的下调赋予肝癌干细胞样特性并预示预后不良。
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1402-9. doi: 10.1245/s10434-014-4242-0. Epub 2014 Nov 18.
3
PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.PRRX1 缺失通过 PITX2/miR-200 依赖的 SLUG/CTNNB1 调控诱导肝癌中的间质-上皮转化。
Cancer Sci. 2021 Jun;112(6):2158-2172. doi: 10.1111/cas.14853. Epub 2021 Apr 8.
4
Dysregulated paired related homeobox 1 impacts on hepatocellular carcinoma phenotypes.调控失常的配对相关同源盒基因 1 影响肝癌表型。
BMC Cancer. 2021 Sep 8;21(1):1006. doi: 10.1186/s12885-021-08637-3.
5
NKD1 correlates with a poor prognosis and inhibits cell proliferation by inducing p53 expression in hepatocellular carcinoma.NKD1与预后不良相关,并通过诱导p53表达抑制肝癌细胞增殖。
Tumour Biol. 2016 Oct;37(10):14059-14067. doi: 10.1007/s13277-016-5173-0. Epub 2016 Aug 9.
6
STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.STYK1 通过 MEK/ERK 和 PI3K/AKT 信号通路促进人肝癌细胞的上皮-间充质转化和肿瘤转移。
Sci Rep. 2016 Sep 15;6:33205. doi: 10.1038/srep33205.
7
NK3 homeobox 1 (NKX3.1) up-regulates forkhead box O1 expression in hepatocellular carcinoma and thereby suppresses tumor proliferation and invasion.NK3 同源盒 1(NKX3.1)上调肝细胞癌中叉头框 O1 的表达,从而抑制肿瘤增殖和侵袭。
J Biol Chem. 2017 Nov 24;292(47):19146-19159. doi: 10.1074/jbc.M117.793760. Epub 2017 Sep 27.
8
MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells.微小RNA-137通过抑制FBI-1来抑制肝癌细胞的增殖以及体外侵袭和迁移。
Tumour Biol. 2016 Oct;37(10):13995-14008. doi: 10.1007/s13277-016-5230-8. Epub 2016 Aug 4.
9
Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma.CDCA5 沉默抑制癌症进展,并作为肝细胞癌的预后生物标志物。
Oncol Rep. 2018 Oct;40(4):1875-1884. doi: 10.3892/or.2018.6579. Epub 2018 Jul 17.
10
MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.微小RNA-451:上皮-间质转化抑制剂及肝细胞癌的预后生物标志物
Oncotarget. 2015 Jul 30;6(21):18613-30. doi: 10.18632/oncotarget.4317.

引用本文的文献

1
New Hepatocellular Carcinoma (HCC) Primary Cell Cultures as Models for Exploring Personalized Anti-TGF-β Therapies Based on Tumor Characteristics.新型肝细胞癌(HCC)原代细胞培养作为基于肿瘤特征探索个性化抗转化生长因子-β(TGF-β)疗法的模型
Int J Mol Sci. 2025 Mar 8;26(6):2430. doi: 10.3390/ijms26062430.
2
PRRX1 silencing is required for metastatic outgrowth in melanoma and is an independent prognostic of reduced survival in patients.PRRX1 沉默是黑色素瘤转移生长所必需的,并且是患者生存时间降低的独立预后因素。
Mol Oncol. 2024 Oct;18(10):2471-2494. doi: 10.1002/1878-0261.13688. Epub 2024 Jul 8.
3
Paired-related homeobox 1 induces epithelial-mesenchymal transition in oesophageal squamous cancer.
配对相关同源盒1诱导食管鳞状细胞癌的上皮-间质转化。
World J Gastrointest Oncol. 2023 Dec 15;15(12):2185-2196. doi: 10.4251/wjgo.v15.i12.2185.
4
HMGB2 upregulation promotes the progression of hepatocellular carcinoma cells through the activation of ZEB1/vimentin axis.HMGB2上调通过激活ZEB1/波形蛋白轴促进肝癌细胞进展。
J Gastrointest Oncol. 2023 Oct 31;14(5):2178-2191. doi: 10.21037/jgo-23-447. Epub 2023 Oct 24.
5
Weighted gene co-expression network analysis reveals prognostic and diagnostic significance of in patients with early and late hepatocellular carcinoma.加权基因共表达网络分析揭示了其在早期和晚期肝细胞癌患者中的预后和诊断意义。 (注:原文中“of”后面缺少具体内容,翻译时根据语境补充为“其”)
J Gastrointest Oncol. 2022 Apr;13(2):768-779. doi: 10.21037/jgo-22-168.
6
Bioinformatics analysis to reveal key biomarkers for early and late hepatocellular carcinoma.生物信息学分析以揭示早期和晚期肝细胞癌的关键生物标志物。
Transl Cancer Res. 2020 Jul;9(7):4070-4079. doi: 10.21037/tcr-19-2238.
7
Dysregulated paired related homeobox 1 impacts on hepatocellular carcinoma phenotypes.调控失常的配对相关同源盒基因 1 影响肝癌表型。
BMC Cancer. 2021 Sep 8;21(1):1006. doi: 10.1186/s12885-021-08637-3.
8
The Regulatory Role of PRRX1 in Cancer Epithelial-Mesenchymal Transition.PRRX1在癌症上皮-间质转化中的调控作用
Onco Targets Ther. 2021 Jul 16;14:4223-4229. doi: 10.2147/OTT.S316102. eCollection 2021.
9
Prrx1 promotes stemness and angiogenesis via activating TGF-β/smad pathway and upregulating proangiogenic factors in glioma.Prrx1 通过激活 TGF-β/smad 通路和上调促血管生成因子促进胶质瘤中的干性和血管生成。
Cell Death Dis. 2021 Jun 15;12(6):615. doi: 10.1038/s41419-021-03882-7.
10
PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.PRRX1 缺失通过 PITX2/miR-200 依赖的 SLUG/CTNNB1 调控诱导肝癌中的间质-上皮转化。
Cancer Sci. 2021 Jun;112(6):2158-2172. doi: 10.1111/cas.14853. Epub 2021 Apr 8.